Biotech Adial Pharmaceuticals Reaches 35% Enrollment in ONWARD(TM) Pivotal Phase 3 Trial of AD04 for the Treatment of Alcohol Use Disorder December 17, 2020
Biotech Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion December 17, 2020
Biotech Atossa Therapeutics Announces Pricing of $14.0 Million Registered Direct Offering Priced At-The-Market December 17, 2020
Biotech Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden December 17, 2020
Biotech Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021 December 17, 2020
Biotech Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution December 17, 2020
Biotech miRagen Enters into License Agreement with Xencor for use of Xtend(TM) Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease December 17, 2020